OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Animal models for the study of depressive disorder
Juhyun Song, Young‐Kook Kim
CNS Neuroscience & Therapeutics (2021) Vol. 27, Iss. 6, pp. 633-642
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Neuroinflammation, memory, and depression: new approaches to hippocampal neurogenesis
Anbiao Wu, Jiyan Zhang
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 84

Immunotherapy for depression: Recent insights and future targets
Ying Bai, Yang Cai, Di Chang, et al.
Pharmacology & Therapeutics (2024) Vol. 257, pp. 108624-108624
Closed Access | Times Cited: 18

Pharmacological activities and pharmacokinetics of liquiritin: A review
Junyuan Qin, Junren Chen, Peng Fu, et al.
Journal of Ethnopharmacology (2022) Vol. 293, pp. 115257-115257
Closed Access | Times Cited: 68

Sex difference in prebiotics on gut and blood–brain barrier dysfunction underlying stress‐induced anxiety and depression
Jiajun Jiang, Yaoyang Fu, Anying Tang, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. S1, pp. 115-128
Open Access | Times Cited: 25

NADPH-oxidases as potential pharmacological targets for thrombosis and depression comorbidity
Patrizia Amadio, Leonardo Sandrini, M Zara, et al.
Redox Biology (2024) Vol. 70, pp. 103060-103060
Open Access | Times Cited: 11

Optogenetics and chemogenetics: key tools for modulating neural circuits in rodent models of depression
Shaowei Li, Jianying Zhang, Jiehui Li, et al.
Frontiers in Neural Circuits (2025) Vol. 19
Open Access | Times Cited: 1

Review of microbiota gut brain axis and innate immunity in inflammatory and infective diseases
Chongshan Yuan, Yuhong He, Kunyu Xie, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 21

The Role of Gasotransmitter-Dependent Signaling Mechanisms in Apoptotic Cell Death in Cardiovascular, Rheumatic, Kidney, and Neurodegenerative Diseases and Mental Disorders
Stanislav Rodkin, Chizaram Nwosu, Alexander Sannikov, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6014-6014
Open Access | Times Cited: 17

Depression in breast cancer patients: Immunopathogenesis and immunotherapy
Sheng Yu, Wen Li, Lingxue Tang, et al.
Cancer Letters (2022) Vol. 536, pp. 215648-215648
Closed Access | Times Cited: 26

Cardamom oil ameliorates behavioral and neuropathological disorders in a rat model of depression induced by reserpine
Alaa A. Abdel-Rasoul, Nabil Saleh, Eman N. Hosny, et al.
Journal of Ethnopharmacology (2023) Vol. 308, pp. 116254-116254
Closed Access | Times Cited: 15

Isochlorogenic acid B alleviates lead-induced anxiety, depression and neuroinflammation in mice by the BDNF pathway
Jia-Xue Shi, Chao Cheng, Hai-Nan Ruan, et al.
NeuroToxicology (2023) Vol. 98, pp. 1-8
Closed Access | Times Cited: 14

Potential Role of Bmal1 in Lipopolysaccharide-Induced Depression-Like Behavior and its Associated "Inflammatory Storm"
Dandan Xu, Zhiqi Hou, Yayun Xu, et al.
Journal of Neuroimmune Pharmacology (2024) Vol. 19, Iss. 1
Closed Access | Times Cited: 4

Postsynaptic Proteins at Excitatory Synapses in the Brain—Relationship with Depressive Disorders
Sylwia Samojedny, Ewelina Czechowska, Patrycja Pańczyszyn-Trzewik, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11423-11423
Open Access | Times Cited: 17

Potential value of Interleukin-6 as a diagnostic biomarker in human MDD and the antidepressant effect of its receptor antagonist tocilizumab in lipopolysaccharide-challenged rats
Dandan Xu, Yayun Xu, Xinran Gao, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110903-110903
Closed Access | Times Cited: 10

Insights for the Next Generation of Ketamine for the Treatment of Depressive Disorder
Allana Cristina Faustino Martins, Bretton Badenoch, Roberto da Silva Gomes
Journal of Medicinal Chemistry (2025)
Closed Access

The light-dark forced swim test for simultaneous assessment of behavioral ‘despair’ and anxiety-like behavior in female mice
Sergey L. Khatsko, Alexander V. Zhdanov, Daria V Kravchenko, et al.
Behavioural Brain Research (2025) Vol. 484, pp. 115492-115492
Closed Access

Activation differentiates illness trajectories among youth seeking mental health care.
Emiliana Tonini, Jacob J. Crouse, Mirim Shin, et al.
Journal of Affective Disorders (2025)
Closed Access

Dynamic alterations of depressive-like behaviors, gut microbiome, and fecal metabolome in social defeat stress mice
Haifeng Yang, Ping Liu, Tao Sun, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access

Toward a Diagnostic Framework for the Equine Depressive Phenotype: A Narrative Review
C. O' Brien, Sebastian D. McBride, Matthew O. Parker
Journal of Veterinary Behavior (2025)
Open Access

Sirtuin 1 underlies depression-related behaviors by modulating the serotonin system in the dorsal raphe nucleus in female mice
Lihong Xu, Yifan Cao, Shasha Zhang, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111400-111400
Closed Access

Page 1 - Next Page

Scroll to top